206 related articles for article (PubMed ID: 20739684)
1. Effect of HLA class I and class II alleles on progression from autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes.
Lipponen K; Gombos Z; Kiviniemi M; Siljander H; Lempainen J; Hermann R; Veijola R; Simell O; Knip M; Ilonen J
Diabetes; 2010 Dec; 59(12):3253-6. PubMed ID: 20739684
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity.
Mikk ML; Pfeiffer S; Kiviniemi M; Laine AP; Lempainen J; Härkönen T; Toppari J; Veijola R; Knip M; Ilonen J;
Pediatr Diabetes; 2020 Nov; 21(7):1218-1226. PubMed ID: 32613719
[TBL] [Abstract][Full Text] [Related]
3. Class II HLA Genotype Association With First-Phase Insulin Response Is Explained by Islet Autoantibodies.
Koskinen MK; Lempainen J; Löyttyniemi E; Helminen O; Hekkala A; Härkönen T; Kiviniemi M; Simell O; Knip M; Ilonen J; Toppari J; Veijola R
J Clin Endocrinol Metab; 2018 Aug; 103(8):2870-2878. PubMed ID: 29300921
[TBL] [Abstract][Full Text] [Related]
4. The association of the HLA-A*24:02, B*39:01 and B*39:06 alleles with type 1 diabetes is restricted to specific HLA-DR/DQ haplotypes in Finns.
Mikk ML; Heikkinen T; El-Amir MI; Kiviniemi M; Laine AP; Härkönen T; Veijola R; Toppari J; Knip M; Ilonen J;
HLA; 2017 Apr; 89(4):215-224. PubMed ID: 28185422
[TBL] [Abstract][Full Text] [Related]
5. Association of protein tyrosine phosphatase non-receptor type 22 gene functional variant C1858T, HLA-DQ/DR genotypes and autoantibodies with susceptibility to type-1 diabetes mellitus in Kuwaiti Arabs.
Haider MZ; Rasoul MA; Al-Mahdi M; Al-Kandari H; Dhaunsi GS
PLoS One; 2018; 13(6):e0198652. PubMed ID: 29924845
[TBL] [Abstract][Full Text] [Related]
6. Accelerated Progression to Type 1 Diabetes in the Presence of
Balke EM; Balti EV; Van der Auwera B; Weets I; Costa O; Demeester S; Abrams P; Casteels K; Coeckelberghs M; Tenoutasse S; Keymeulen B; Pipeleers DG; Gorus FK;
Diabetes Care; 2018 May; 41(5):1076-1083. PubMed ID: 29545461
[TBL] [Abstract][Full Text] [Related]
7. Do non-HLA genes influence development of persistent islet autoimmunity and type 1 diabetes in children with high-risk HLA-DR,DQ genotypes?
Steck AK; Zhang W; Bugawan TL; Barriga KJ; Blair A; Erlich HA; Eisenbarth GS; Norris JM; Rewers MJ
Diabetes; 2009 Apr; 58(4):1028-33. PubMed ID: 19188433
[TBL] [Abstract][Full Text] [Related]
8. Millennium award recipient contribution. Identification of children with early onset and high incidence of anti-islet autoantibodies.
Robles DT; Eisenbarth GS; Wang T; Erlich HA; Bugawan TL; Babu SR; Barriga K; Norris JM; Hoffman M; Klingensmith G; Yu L; Rewers M;
Clin Immunol; 2002 Mar; 102(3):217-24. PubMed ID: 11890708
[TBL] [Abstract][Full Text] [Related]
9. Age at Seroconversion, HLA Genotype, and Specificity of Autoantibodies in Progression of Islet Autoimmunity in Childhood.
Bauer W; Veijola R; Lempainen J; Kiviniemi M; Härkönen T; Toppari J; Knip M; Gyenesei A; Ilonen J
J Clin Endocrinol Metab; 2019 Oct; 104(10):4521-4530. PubMed ID: 31120497
[TBL] [Abstract][Full Text] [Related]
10. The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos.
Bugawan TL; Klitz W; Alejandrino M; Ching J; Panelo A; Solfelix CM; Petrone A; Buzzetti R; Pozzilli P; Erlich HA
Tissue Antigens; 2002 Jun; 59(6):452-69. PubMed ID: 12445315
[TBL] [Abstract][Full Text] [Related]
11. Genetic susceptibility to type 1 diabetes in childhood - estimation of HLA class II associated disease risk and class II effect in various phases of islet autoimmunity.
Ilonen J; Kiviniemi M; Lempainen J; Simell O; Toppari J; Veijola R; Knip M;
Pediatr Diabetes; 2016 Jul; 17 Suppl 22():8-16. PubMed ID: 27411431
[TBL] [Abstract][Full Text] [Related]
12. Geographical variation in risk HLA-DQB1 genotypes for type 1 diabetes and signs of beta-cell autoimmunity in a high-incidence country.
Kukko M; Virtanen SM; Toivonen A; Simell S; Korhonen S; Ilonen J; Simel O; Knip M
Diabetes Care; 2004 Mar; 27(3):676-81. PubMed ID: 14988284
[TBL] [Abstract][Full Text] [Related]
13. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).
Barker JM; Barriga KJ; Yu L; Miao D; Erlich HA; Norris JM; Eisenbarth GS; Rewers M;
J Clin Endocrinol Metab; 2004 Aug; 89(8):3896-902. PubMed ID: 15292324
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Pattern of First-Phase Insulin Response Is Associated With Genetic Variants Outside the Class II HLA Region in Children With Multiple Autoantibodies.
Koskinen MK; Mikk ML; Laine AP; Lempainen J; Löyttyniemi E; Vähäsalo P; Hekkala A; Härkönen T; Kiviniemi M; Simell O; Knip M; Veijola R; Ilonen J; Toppari J
Diabetes; 2020 Jan; 69(1):12-19. PubMed ID: 31591105
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
[TBL] [Abstract][Full Text] [Related]
16. Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetes.
Redondo MJ; Babu S; Zeidler A; Orban T; Yu L; Greenbaum C; Palmer JP; Cuthbertson D; Eisenbarth GS; Krischer JP; Schatz D;
J Clin Endocrinol Metab; 2006 May; 91(5):1705-13. PubMed ID: 16464953
[TBL] [Abstract][Full Text] [Related]
17. Insulin-dependent diabetes mellitus in non-DR3/non-DR4 subjects.
Dubois-Laforgue D; Timsit J; Djilali-Saiah I; Boitard C; Caillat-Zucman S
Hum Immunol; 1997 Oct; 57(2):104-9. PubMed ID: 9438201
[TBL] [Abstract][Full Text] [Related]
18. Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children.
Sugihara S; Sakamaki T; Konda S; Murata A; Wataki K; Kobayashi Y; Minamitani K; Miyamoto S; Sasaki N; Niimi H
Diabetes; 1997 Nov; 46(11):1893-7. PubMed ID: 9356042
[TBL] [Abstract][Full Text] [Related]
19. The Influence of Type 1 Diabetes Genetic Susceptibility Regions, Age, Sex, and Family History on the Progression From Multiple Autoantibodies to Type 1 Diabetes: A TEDDY Study Report.
Krischer JP; Liu X; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Akolkar B;
Diabetes; 2017 Dec; 66(12):3122-3129. PubMed ID: 28903990
[TBL] [Abstract][Full Text] [Related]
20. Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes.
Triolo TM; Baschal EE; Armstrong TK; Toews CS; Fain PR; Rewers MJ; Yu L; Miao D; Eisenbarth GS; Gottlieb PA; Barker JM
J Clin Endocrinol Metab; 2009 Nov; 94(11):4517-23. PubMed ID: 19820007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
